Carrillo-Barreras RL, Baza-Salinas JG, Rodríguez-Ledesma MA

Language: Spanish
References: 21
Page: 655-658
PDF size: 31.89 Kb.

ABSTRACT

Background: A predictive model of breast cancer risk is the Breast Cancer Risk Assessment Tool (BCRAT), designed by scientists at the National Cancer Institute. The objective was to determine the risk of breast cancer (BC) through the BCRAT.
Methods: a descriptive, prospective, observational study was done. We included 300 women over 35 years of age to who we applied the BCRAT. We excluded women previously diagnosed with BC.
Results: the predominant age range was 35-45 years with 43.3 %; married 79.3 % and 56.3 % housewives, the respondents were Hispanic population. The statistical analysis showed significant age over 50 years and family background as major risk factors, respectively (OR = 5.06, p = 0.02) (OR = 27.75, p = 0.000), previous breast biopsy increases the risk (OR = 5.3, p = 0.009). Conclusions: according to the literature, the results obtained
showed that sex, age over 50 years; family history and previous conduct breast biopsy are the most important risk factors. According to the BCRAT risk was determined by averaging 0.6 probabilities to develop BC at five years in women over 35 years.

REFERENCES

1. Zulaica C. Cancer de mama. Guías Clínicas 2007;7(36). [Consultado el 20 de mayo de 2009]. Disponible en http:// www.fisterra.com/GUIAS2/MAMA.ASP

2. Instituto Nacional de Estadística y Geografía, INEGI. [Sitio web]. Estadísticas vitales. [Consultado el 12 de junio de 2009]. Disponible en http://www.inegi.org.mx/contenidos/ español/estadisticas2006/

3. Rodríguez S, Carpuso M. Epidemiología del cáncer de mama. Ginecol Obstet Mex 2006;74(11):585-593.

4. Secretaría de Salud. Norma Oficial Mexicana NOM-041- SSA2-2002, para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama. Diario Oficial de la Federación [Consultado el 25 de abril de 2009]. Disponible en http://www.salud.gob.mx/unidades/ cdi/nom/041ssa202.html

5. Chan A, Pintilie M, Vallis K, Girourd C, Goss P. Breast cancer in women < 35 years: review of 1002 cases from a single institution. Ann Oncol 2000;11(10):1255-1262.

6. Thull DL, Voguel VG. Recognition and management of hereditary breast cancer syndromes. Oncologist 2004;9 (1):13-24.

7. Rubin P, Williams J, editores. Oncología clínica. Enfoque multidisciplinario para médicos y estudiantes. Octava edición. Madrid, España: Elsevier Science; 2003. p. 267-299.

8. Chlebowsky R, Chen Z, Anderson G. Ethnicity and breast cáncer: factor influencing differences in incidence and outcome. J Natl Cancer Inst 2005;97(6):439-448.

9. Romero FM, Santillán AL, Olvera HP, Morales SM. Frecuencia de factores de riesgo de cáncer de mama. Ginecol Obstet Mex 2008;76(11):667-672.

10. Kahlenborn C, Modugno F, Potter D. Uso de anticonceptivos orales como factor de riesgo de cáncer de mama premenopáusico: un metaanálisis. Mayo Clin Proc 2006; 81(10):1290-1302.

11. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al.; American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57(2):75-89.

12. Torres-Arreola L, Doubova SV. Cáncer de mama, detección oportuna en el primer nivel de atención. Rev Med Inst Mex Seguro Soc 2007;45(2):157-66.

13. Boyd N, Guo H, Martin L, Sun L, Stone J. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356(3):227-236.

14. Vacek PM, Geller BM. A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomark Prev 2004;13(5): 715-722.

15. Gómez F. Evaluación cuantitativa del riesgo de cáncer de mama. Rev Med Clin Condes 2006;17(4):149-163.

16. Knutson D, Steiner E. Screening for breast cáncer: current, recommendations and future directions. Am Fam Physician 2007;75(11):1660-1666.

17. Freedman AN, Seminara D, Gail M, Hartge P, et al. Cancer risk prediction models: a workshop on development evaluation and application. J Nat Cancer Inst 2005;97(10):715-723.

18. Steiner E, Klumbert D, Knutson D. Assessing breast cancer risk in women. Am Fam Physician 2008;78(12): 1361-1366.

19. Medina FH, Garza E, Gabilondo PB, Gaona LP. Riesgo de cáncer de mama invasor en población mexicana, patrones de escrutinio y profilaxis. Rev Invest Clin 2004;56 (4):422-426.

20. Vogel VG. Epidemiología, genética y evaluación del riesgo de cáncer de mama en mujeres posmenopáusicas. Rev Climaterio 2009;12(70):121-133.

21. Márquez A, Trujillo R. Cáncer de mama hereditario. MedSpain. [Consultado el 12 de junio de 2009]. Disponible en http://www.airtel.net/personal/rafaeltrujillo.